Economic Evaluation of a New Antiemetic Drug – Palonosetron versus Ondansetron: Assessment of the Drug Price Ratio in Five European Countries

Author： Tarricone Rosanna   Girolami Federica  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.25, Iss.9, 2005-01, pp. : 597-608

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug Use Evaluation of Ondansetron in Postoperative Nausea and Vomiting

By  

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 37, Iss. 1, 2007-03 ,pp. : 11-15

John Wiley & Sons Inc

Access to resources Recommend Favorite

Ondansetron-loaded chitosan microspheres for nasal antiemetic drug delivery: an alternative approach to oral and parenteral routes

By Gungor Sevgi   Okyar Alper   Erturk-Toker Sidika   Baktir Gul   Ozsoy Yildiz  

Drug Development and Industrial Pharmacy, Vol. 36, Iss. 7, 2010-07 ,pp. : 806-813

Informa Healthcare

Access to resources Recommend Favorite

The European Medicines Evaluation Agency: role of experts in drug assessment

By Benzi G.  

Trends in Pharmacological Sciences, Vol. 16, Iss. 12, 1995-12 ,pp. : 409-412

Elsevier

Access to resources Recommend Favorite

Ondansetron: Drug hypersensitivity: case report

By  

Reactions Weekly, Vol. 1, Iss. 1216, 2008-01 ,pp. : 27-27

Adis International

Access to resources Recommend Favorite

New report recommends US drug price cuts

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 286, 2000-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite